E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Correlation between the TIMI risk score and high-risk angiographic findings in non–ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial
Jessica L. Mega,David A. Morrow,Marc S. Sabatine,Xue Qiao Zhao,Steven M. Snapinn,Peter M. DiBattiste,C. Michael Gibson,Elliott M. Antman,Eugene Braunwald,Pierre Théroux +9 more
TL;DR: The TIMI risk score identifies patients who are more likely to have intracoronary thrombus, impaired flow, and increased burden of coronary atherosclerosis, likely explaining in part the particular benefit of potent antithrombin and antiplatelet agents among patients with higher risk scores.
Journal ArticleDOI
Spontaneous closure of ventricular septal defect, anatomic proof in an adult with tricuspid atresia.
TL;DR: An adult patient in whom the diagnosis of tricuspid atresia was established and who died after operation was studied, and there was unequivocal evidenee that a functional veentricular septal defect had been present and had subsequently closed.
Journal ArticleDOI
Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial
Michael L. Terrin,David O. Williams,Neal S. Kleiman,James T. Willerson,Hiltrud S. Mueller,P Desvigne-Nickens,P Desvigne-Nickens,S A Forman,S A Forman,G L Knatterud,G L Knatterud,Eugene Braunwald,Eugene Braunwald +12 more
TL;DR: TIMI II invasive and conservative strategies resulted in similar favorable outcomes after 2 and 3 years, and Mortality and reinfarction rates in the two strategies were comparable.
Journal ArticleDOI
The influence of intracardiac baroreceptors on venous return, systemic vascular volume and peripheral resistance.
TL;DR: Investigations were undertaken to determine whether or not these hemodynamic parameters are also modified by activation of intracardiac baroreceptors, and to localize these receptors within the heart.
Journal ArticleDOI
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.
Marc P. Bonaca,Robert F. Storey,Pierre Theroux,P. Gabriel Steg,Deepak L. Bhatt,Marc Cohen,KyungAh Im,Sabina A. Murphy,Giulia Magnani,Ton Oude Ophuis,Mikhail Rudah,Alexander Parkhomenko,Daniel Isaza,Gabriel Kamensky,Assen Goudev,Gilles Montalescot,Eva C. Jensen,Per Johanson,Eugene Braunwald,Marc S. Sabatine +19 more
TL;DR: The efficacy of low-dose ticagrelor is consistent over time with a trend toward less excess bleeding, and patients with a history of MI remain at persistent high risk for CVD, MI, and stroke as late as 5 years after MI.